James Catto
Professor James Catto has made Sheffield a leading centre for urological cancers. He has authored over 390 articles (>38,000 citations, h-index 87) and raised £34M in funding (including MRC, NIHR, Wellcome Trust, CRUK and EU). As Editor-in-Chief of European Urology, he increased the impact factor from 10.2 to 24.3, and launched three sister journals. He has served the NICE Bladder cancer guidelines, Dept. of Health cancer experts’ group, NCRI–CSG, helped design the NHS Blood in Pee campaign and multiple specialty committees. He has trained the next generation of surgeons in academia (supervised 13 PhD students, six6 NIHR ACFs, three NIHR Clinical Lecturers, one Senior Clinical lecturer and numerous Academic F2/BMed Sci/MSc students) and surgery (arranged multiple fellowships to Australia and Canada). He is an NIHR mentor to other academic surgeons. He firmly believes in clinical trials and has recruited more than 5000 patients in Sheffield (for which he received an NIHR commendation in 2019). He has received awards from national (BAUS: Golden Telescope, 2014 and BARD Medal, 2004) and international societies (EAU: Franz Debruyne Lifetime achievement 2023, Crystal Matula, 2010, Best PhD Thesis, 2005). He was appointed Chair of Urological Surgery in Sheffield in 2014, Honorary Senior Clinical Research Fellow, University of Oxford in 2013, and Honorary Clinical Professor, University College London in 2016.